Swiss All Share Index
17.840,19
PKT
-130,78
PKT
-0,73
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.10.17 | Nestlé Outperform | RBC Capital Markets | |
| 24.10.17 | UBS buy | Goldman Sachs Group Inc. | |
| 24.10.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 24.10.17 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.10.17 | Roche Neutral | UBS AG | |
| 23.10.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 23.10.17 | Novartis Neutral | UBS AG | |
| 23.10.17 | UBS buy | Citigroup Corp. | |
| 23.10.17 | UBS buy | Citigroup Corp. | |
| 23.10.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.10.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 23.10.17 | Swiss Re Hold | Jefferies & Company Inc. | |
| 23.10.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 20.10.17 | Roche Equal-Weight | Morgan Stanley | |
| 20.10.17 | Novartis overweight | Morgan Stanley | |
| 20.10.17 | Givaudan overweight | JP Morgan Chase & Co. | |
| 20.10.17 | Holcim Neutral | JP Morgan Chase & Co. | |
| 20.10.17 | Roche Hold | Deutsche Bank AG | |
| 20.10.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 20.10.17 | Roche Hold | Kepler Cheuvreux | |
| 20.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.10.17 | Nestlé buy | Goldman Sachs Group Inc. | |
| 20.10.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 20.10.17 | Nestlé buy | Baader Bank | |
| 20.10.17 | Roche Reduce | HSBC | |
| 19.10.17 | Roche Neutral | UBS AG | |
| 19.10.17 | Roche Hold | Baader Bank | |
| 19.10.17 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 19.10.17 | Nestlé buy | Baader Bank | |
| 19.10.17 | Nestlé buy | UBS AG | |
| 19.10.17 | Roche overweight | JP Morgan Chase & Co. | |
| 19.10.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 18.10.17 | Roche Neutral | Citigroup Corp. | |
| 18.10.17 | Holcim Neutral | JP Morgan Chase & Co. | |
| 17.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.10.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 16.10.17 | Holcim Neutral | UBS AG | |
| 16.10.17 | Roche overweight | JP Morgan Chase & Co. |